Pharminent

AstraZeneca at Cannes: Healthcare delivery’s speeding away from pharma’s marketing model

Can smartphones upend commerce in biopharma? AstraZeneca thinks they might, which is why the U.K.-based drug giant teamed up with Babylon Health in an artificial intelligence pilot project that’s more healthcare than pharma. http://www.fiercepharma.com/marketing/az-at-cannes-healthcare-delivery-speeding-away-from-pharma-model

Filed under: Marketing

What marketers need to know about tax reform, off-label promotion, pricing

The ad-tax deduction is likely once again on the table. http://www.mmm-online.com/legalregulatory/what-marketers-need-to-know-about-tax-reform-off-label-promotion-pricing/article/662241/

Filed under: Marketing

The Impact of AI and Machine Learning in Marketing

In the new world of artificial intelligence and machine learning, predictive content is digital content that automatically assembles itself in real-time for each impression with deep and precise predictive intelligence. In marketing and consumer engagement, this is as close to personalization at scale that we, as marketers, have to date. Up until now, many have […] https://www.pm360online.com/the-impact-of-ai-and-machine-learning-in-marketing/

Filed under: Marketing

Roche creates the Fight IPF choir for disease awareness campaign

Aims to raise the lung disease’s profile and
inform patients and their families http://www.pmlive.com/pharma_news/roche_creates_the_fight_ipf_choir_for_disease_awareness_campaign_1172955

Filed under: Marketing

Politics led to DTC uproar, but curbs unlikely in current climate

Anti-DTC measures are unlikely to be enacted even though the backlash itself is a function of political change. http://www.mmm-online.com/politics-led-to-dtc-uproar-but-curbs-unlikely-in-current-climate/article/485125/

Filed under: Marketing

DTC TV ad spending fell in December, but Pfizer topped peers

December’s DTC television ad spending declined to $107 million.  http://www.biopharmadive.com/news/dtc-tv-ad-spending-fell-in-december-but-pfizer-topped-peers/412777/

Filed under: Marketing

What the AMA’s Proposed DTC Ban Overlooks

While DTC advertising does significantly impact consumer demand, most evidence suggests the majority of this demand benefits the overall state of consumer health. http://www.mmm-online.com/campaigns/what-the-amas-proposed-dtc-ban-overlooks/article/465809/?utm

Filed under: Marketing

AMA calls for DTC advertising ban

The American Medical Association voted in support of banning DTC advertising.
http://www.mmm-online.com/commercial/ama-calls-for-dtc-advertising-ban/article/454546/

Filed under: Marketing

Are doctors more willing to see pharma sales reps now?

http://pharmalot.com/are-doctors-more-willing-to-see-pharma-sales-reps-now/

Filed under: Marketing

Drug Firms Buy Pricey Vouchers to Speed Products to Market

Sanofi and Regeneron beat Amgen to market with their drug, Praluent, even though Amgen applied for approval of its own PCSK9 drug first.
http://www.wsj.com/articles/drug-firms-buy-pricey-vouchers-to-speed-products-to-market-1445333403?mod=yahoo_hs

Filed under: Marketing

EU and UK Physician Payment Sunshine Coming – May Eclipse US Version

http://pharmamkting.blogspot.com/2015/10/eu-and-uk-physician-payment-sunshine.html

Filed under: Marketing

Competitive Trial Management: Winning with Clinical Studies

Savvy companies are leveraging clinical trials as competitive weapons in the larger brand wars.

read more http://www.pharmexec.com/competitive-trial-management-winning-clinical-studies

Filed under: Marketing

Cloud Marketing: Faces in the Cloud

As the need for more informed conversations with KOLs has grown, so too has the role of medical science liaisons. But as they attempt to bolster trust and familiarity with those audiences, MSLs are challenged by the volume of personalized information they need at their disposal to engage in a meaningful way. Enter—what else?—the cloud. Veeva Systems’ Robert Groebel explains http://www.mmm-online.com/cloud-marketing-faces-in-the-cloud/article/440390/

Filed under: Marketing

Has the era of the super successful pharma sales rep really come to an end?

We spoke with John Crowley, author of the Accenture report “The Rebirth of the Pharmaceutical Sales Force,” to gain insights into why some pharma sales reps are actually doing better than ever. http://www.biopharmadive.com/news/has-the-era-of-the-super-successful-pharma-sales-rep-really-come-to-an-end/406139/

Filed under: Marketing

First Year After Launch — Special Feature

PharmaLive

Filed under: Marketing

Categories